Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
crispr
deals
3
×
gene editing
3
×
life sciences
national blog main
san francisco blog main
biotech
boston
national top stories
san francisco top stories
vc
abbvie
administration
allergan
alzheimer's
alzheimer's disease
amgen
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
biontech
boulder/denver blog main
boulder/denver top stories
breakpoint therapeutics
cancer
car-t
celgene
celyad
clinical trials
cynthia collins
david walt
deafness
detroit blog main
detroit top stories
diagnostics
dialysis
dna damage
donald trump
What
gene
3
×
bio
editing
medicines
abbvie
alliance
becker
billions
biotech
create
crispr
diagnostic
diseases
dollars
eaton
editas
exits
experimental
fix
genetic
healthcare
heats
high
human
impact
launches
life
michael
millions
moves
pact
partnership
patients
pruning
race
research
returning
rights
roundup
science
Language
unset
Current search:
deals
×
gene
×
" gene editing "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M